US President Donald Trump has upped the ante over the weekend: on Sunday evening he threatened “way more” than what was initially introduced Wanting to withdraw 5,000 US soldiers from Germany. Within the subsequent six to 12 months, the US Division of Protection needs to make use of a part of its Troops from the Federal Republic embarrassed. It’s nonetheless unclear which of the roughly 20 places, primarily positioned in southwest Germany, could possibly be affected. Along with the safety coverage implications that this step would have for Germany and Europe, it may even have penalties for the affected areas economic consequences have. The set off for the US authorities’s choice could possibly be the Statements by Federal Chancellor Friedrich Merz to have been at a college within the Sauerland. There, Merz criticized the American actions in Iran and expressed doubts in regards to the US technique. How essential Germany is as a hub for the USA for its actions within the Close to and Center East and who can be harm extra by such a partial withdrawal of US troops is defined Paul MiddelhoffUS correspondent for TIME.
The hope within the combat in opposition to Alzheimer’s at present has two names: Lecanemab and Donanemab. Since autumn 2025 the new medications are also available in Germany, and for the primary time they not solely assault signs, but in addition goal one of many causes of the illness. Researchers converse of a turning level, some even of a brand new period. Alzheimer’s is by far the commonest dementia, accounting for two-thirds of all instances. However at the least in Germany, progress is briefly slowed: the Federal Joint Committee has not but seen any clear further profit in comparison with present therapies. His judgment is essential for worth negotiations between medical health insurance corporations and producers. What penalties does this have for sufferers? And what does the G-BA’s ruling imply for the continued combat in opposition to the illness? Talks about it Tom Kattwinkeleditor within the well being division at ZEIT, within the podcast.
And in any other case? Yoko Ono against French beer brand “John Lemon”
Moderation and manufacturing: Moses Fendel
Cooperation: Konstantin Hadzi-Vuković, Christina Felschen
You can find all episodes of our podcast here. Questions, criticism, recommendations? You’ll be able to attain us at wasjetzt@zeit.de.